Novel imaging agent identifies biomarker for iron-targeted cancer therapies
A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted
Read more
Novel MRI contrast agent sidesteps toxic effects of current products
Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image quality and allows radiologists who interpret MRI scans
Read more
New contrast agent for early diagnosis of brain metastases
A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) have found a way to
Read more